US$ 20.08
glp-1 and type 1 diabetes In patients with residual ß-cell function, treatment Mechanisms of action of GLP-1RA.
Description
Some platforms charge per message or limit you to a certain number of interactions

[DOI] [PMC free article] [PubMed] [Google Scholar] 55.Minhas P.S., Liu L., Moon P.K., Joshi A.U., Dove C., Mhatre S., Contrepois K., Wang Q., Lee B.A., Coronado M., et al

The researchers note that further studies are needed to determine the causality between the drug and the increased incidence of NAION

Jastreboff, A.M., et al., Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial

Do not stop treatment without medical advice, as abrupt discontinuation can worsen glycaemic control
